Plasma membrane‐dependent activation of gelatinase A in human vascular endothelial cells
Authors:
- 1 December 1995
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 165 (3) , 475-483
Abstract
The initiation of the angiogenic process requires a locally confined and time‐limited proteolysis of the basement membrane (BM) components at the site of new vessel sprout. Gelatinase A, a member of the matrix metalloproteinase family, degrades BM type IV collagen and is involved in the BM breakdown by migrating tumor cells and endothelial cells (EC). Gelatinase A is synthesized as latent proenzyme and must be activated in order to express its proteolytic activity. A plasma membrane‐dependent mechanism of activation has been described for several tumor and transformed cell lines. In the present study, we show that latent (72 kD) and mature (62‐59 kD) froms of gelatinase A are present in EC membrane fraction from Triton X‐114 extract while only latent form is found in the cytosolic fraction. The incubation of EC membrane fraction with exogenous latent gelatinase A resulted in a significant activation giving rise to 62–59 kD mature forms. 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA), a strong potentiator of angiogenesis in vitro and in vivo, increases the amount of both latent and activated forms of gelatinase A in EC membrane fraction as well as the ability of this latter fraction to activate exogenous latent gelatinase A. We show that the mRNA transcript coding for the membrane‐integrated MMP, the MT‐MMP, previously described as a potential gelatinase A activator in invasive tumor cells is also expressed in vascular EC and is regulated through a TPA sensitive process. This enzyme may be responsible for membrane‐dependent gelatinase A activation in normal vascular EC and may therefore be a determinant in the control of BM proteolysis during angiogenesis. © 1995 Wiley‐Liss Inc.Keywords
This publication has 28 references indexed in Scilit:
- Cell surface binding of TIMP‐2 and pro‐MMP‐2/TIMP‐2 complexFEBS Letters, 1995
- Reciprocated matrix metalloproteinase activation: A process performed by interstitial collagenase and progelatinase ABiochemistry, 1994
- Inhibition of angiogenesis by tissue inhibitor of metalloproteinaseJournal of Cellular Physiology, 1994
- Human progelatinase A can be activated by matrilysinFEBS Letters, 1994
- Structural biochemistry and activation of matrix metalloproteasesCurrent Opinion in Cell Biology, 1993
- Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitroJournal of Cellular Physiology, 1993
- Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complexKidney International, 1993
- Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Tumor-promoting phorbol esters induce angiogenesis in vitroCell, 1985
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973